Case Study · Clinical Research Technology eResearchTechnology

Over more than six years, Hayden IR ran eResearchTechnology’s full IR program, from news releases to quarterly calls. The share price rose 1,030%, institutional holders grew from one to more than 130 and six firms initiated research coverage.

1,030%

Share Price Increase

Company
eResearchTechnology, Inc.
Ticker
Nasdaq: ERT
Sector
Life Sciences & Healthcare
Industry
Clinical Research Technology
Engagement
1999–2006

01 · Challenge

The Challenge

Hayden IR represented eResearchTechnology from August 1999 to March 2006, starting from a split-adjusted share price of $0.81, a single institutional investor and no research coverage. Following rapid price appreciation, the company later faced regulatory challenges and a management change.

02 · Solution

Our Solution

  • Wrote and disseminated all news releases
  • Developed a corporate profile for use with the investment community
  • Targeted and arranged meetings with the financial community and prepared the presentation
  • Initiated quarterly conference calls and webcasts and prepared accompanying scripts
  • Handled investor and prospective investor calls, requests for information, list maintenance and other IR functions
  • Consulted through regulatory challenges and a management change, minimizing share price erosion

03 · Impact

The Impact

  • Share price rose 1,030%, from $0.81 (August 26, 1999) to $9.15 (May 22, 2007), with a high of $29.94 in late 2004
  • Average trading volume increased from 25,000 to 400,000 shares
  • Institutional ownership rose from one investor to more than 130, accounting for 66% of shares outstanding
  • Research coverage increased from zero to six firms
  • Included in the Russell 3000 and Russell 2000 indices
  • Widespread media coverage, including BusinessWeek, CIO Magazine, Investor’s Business Daily, Barron’s and The Wall Street Journal

Past results are not indicative of future performance. Figures are as reported in Hayden IR’s case study for eResearchTechnology, Inc. See our disclosures.

We’d Like to Help Your Company Drive Its IR Agenda to a Higher Level of Efficiency and Effectiveness.